Pfizer is among the prime makers of Covid-19 vaccines.(File) New York: American drugmaker Pfizer is near a deal to buy International Blood Therapeutics, which manufactures a just lately authorised drug towards sickle-cell anemia, for $5 billion, the Wall Avenue Journal has reported. Pfizer, one of many prime makers of Covid-19 vaccines, hopes to conclude talks…

Read More